Presented for research literature review only Johnson JA (1992)
A growing wave of research is showing the medical potential of GLP-1 therapies beyond weight loss
Brand-name medication costs Brand-name tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) carries a higher list price than brand-name semaglutide (Wegovy for weight loss, Ozempic for diabetes)
Mitochondria generate the majority of cellular ROS as a byproduct of oxidative phosphorylation, and mitochondrial GSH is the primary defense against this constant oxidative burden
They do not work in the same way as GLP-1 medicines. At Simply Meds Online, we only offer weight loss treatments that are evidence-based, clinically tested, and prescribed by UK-registered professionals
5 This figure is based on self-reported member data that has not been independently verified